SARS-CoV-2 Tests: Bridging the Gap Between Laboratory Sensors and Clinical Applications
dc.contributor.author | Toropov, N | |
dc.contributor.author | Osborne, E | |
dc.contributor.author | joshi, lovleen | |
dc.contributor.author | Davidson, J | |
dc.contributor.author | Morgan, C | |
dc.contributor.author | Page, J | |
dc.contributor.author | Pepperell, J | |
dc.contributor.author | Vollmer, F | |
dc.date.accessioned | 2021-08-10T11:37:24Z | |
dc.date.issued | 2021-08-14 | |
dc.identifier.issn | 2379-3694 | |
dc.identifier.issn | 2379-3694 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/17549 | |
dc.description.abstract |
This review covers emerging biosensors for SARS-CoV-2 detection together with a review of the biochemical and clinical assays that are in use in hospitals and clinical laboratories. We discuss the gap in bridging the current practice of testing laboratories with nucleic acid amplification methods, and the robustness of assays the laboratories seek, and what emerging SARS-CoV-2 sensors have currently addressed in the literature. Together with the established nucleic acid and biochemical tests, we review emerging technology and antibody tests to determine the effectiveness of vaccines on individuals. | |
dc.format.extent | 2815-2837 | |
dc.format.medium | Print-Electronic | |
dc.language | en | |
dc.language.iso | en | |
dc.publisher | American Chemical Society | |
dc.rights | Attribution 4.0 International | |
dc.rights | Attribution 4.0 International | |
dc.rights | Attribution 4.0 International | |
dc.rights | Attribution 4.0 International | |
dc.rights | Attribution 4.0 International | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | coronavirus | |
dc.subject | SARS-CoV-2 | |
dc.subject | clinical tests | |
dc.subject | PCR | |
dc.subject | RNA | |
dc.subject | mutations | |
dc.subject | lateral flow devices | |
dc.subject | sensors | |
dc.subject | biosensors | |
dc.subject | electrical sensors | |
dc.subject | optical sensors | |
dc.subject | mechanical sensors | |
dc.title | SARS-CoV-2 Tests: Bridging the Gap Between Laboratory Sensors and Clinical Applications | |
dc.type | journal-article | |
dc.type | Journal Article | |
dc.type | Review | |
plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000692037700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
plymouth.issue | 8 | |
plymouth.volume | 6 | |
plymouth.publication-status | Published | |
plymouth.journal | ACS sensors | |
dc.identifier.doi | 10.1021/acssensors.1c00612 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/Faculty of Health/School of Biomedical Sciences | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine | |
plymouth.organisational-group | /Plymouth/Users by role | |
plymouth.organisational-group | /Plymouth/Users by role/Academics | |
dc.publisher.place | United States | |
dcterms.dateAccepted | 2021-07-28 | |
dc.rights.embargodate | 2022-8-14 | |
dc.identifier.eissn | 2379-3694 | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.1021/acssensors.1c00612 | |
rioxxterms.licenseref.uri | http://creativecommons.org/licenses/by/4.0/ | |
rioxxterms.licenseref.startdate | 2021-08-14 | |
rioxxterms.type | Journal Article/Review |